Yasin Keshvargar
Lawyers
Filters
Averin Capital Acquisition $250 million IPO
We advised the underwriters on the IPO
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
Vistra $2.25 billion secured notes offering
We advised the underwriters on the offering
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Vistra $2 billion Cogentrix Energy bridge acquisition financing
We advised the lead arranger, lender and administrative agent on the financing
OceanFirst Financial $225 million private placement
We are advising the placement agent on the transaction
Urban One capital raise and refinancing transaction
We advised an ad hoc group of noteholders on the transaction
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Sabre $1 billion senior secured notes issued in a pari plus structure
We advised Sabre on its high-yield notes offering and related intercompany loan